Stock Events

Stock Events

Mirati Therapeutics 

$58.70
26
-$0.10-0.17% Monday 21:00

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
3.38B
P/E Ratio
-3.11
Dividend Yield
-
Dividend
-

Earnings

26FebExpected
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-3.55
-3.2
-2.84
-2.49
Expected EPS
-2.6
Actual EPS
N/A

Financials

-5,957.44%Profit Margin
Unprofitable
2017
2018
2019
2020
2021
2022
12.44MRevenue
-740.87MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MRTX. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Health Technology
Biotechnology
Manufacturing
Pharmaceutical Preparation Manufacturing
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase I/II clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; and sitravatinib, a spectrum-selective kinase inhibitor that is in Phase II clinical trial for the treatment of NSCL cancer, as well as a KRAS G12D inhibitor program, which is in preclinical development. It has a collaboration and license agreement with BeiGene, Ltd. to develop, manufacture, and commercialize sitravatinib; and a clinical collaboration agreement with Novartis Pharmaceuticals Corporation. Mirati Therapeutics, Inc. was founded in 1995 and is headquartered in San Diego, California.
Show more...
CEO
Charles Baum
Employees
199
Country
United States
ISIN
US60468T1051
WKN
000A1W1XV

Listings

MU
DE
26M.MU
STU
DE
26M.STU

0 Comments

Share your thoughts

FAQ

What is Mirati Therapeutics stock price today?▼
The current price of MRTX is $58.70 USD — it has decreased by -0.17% in the past 24 hours. Watch Mirati Therapeutics stock price performance more closely on the chart.
What is Mirati Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Mirati Therapeutics stocks are traded under the ticker MRTX.
What is Mirati Therapeutics market cap?▼
Today Mirati Therapeutics has the market capitalization of 3.38B
What is Mirati Therapeutics revenue for the last year?▼
Mirati Therapeutics revenue for the last year amounts to 12.44M USD.
What is Mirati Therapeutics net income for the last year?▼
MRTX net income for the last year is -740.87M USD.
How many employees does Mirati Therapeutics have?▼
As of July 08, 2026, the company has 199 employees.
In which sector is Mirati Therapeutics located?▼
Mirati Therapeutics operates in the Manufacturing sector.
When did Mirati Therapeutics complete a stock split?▼
Mirati Therapeutics has not had any recent stock splits.
Where is Mirati Therapeutics headquartered?▼
Mirati Therapeutics is headquartered in San Diego, United States.